Andrew Wilber, Ph.D., has joined the faculty at Southern Illinois University School of Medicine as an assistant professor of urology. He also is a member of the research team at the SimmonsCooper Cancer Institute. Before joining SIU, he was a postdoctoral fellow in the experimental hematology department at St. Jude Children’s Research Hospital in Memphis (2007).
Wilber completed his doctoral studies in the molecular, cellular, developmental biology and genetics department at the University of Minnesota in Minneapolis (2006). He earned his bachelor’s degree in biology and chemistry at Millikin University in Decatur, Ill. (1996).
His is a member of the American Society of Gene Therapy and the International Society of Experimental Hematology. He has published several journal articles and book chapters. His research interest is applying molecular genetic methods to the treatment of bladder and prostate cancer.
Wilber is maintaining a collaboration with Dr. Arthur Nienhuis at St. Jude Children’s Research Hospital. The goals of this project are to test potential “activating factors” of the gamma-globin gene in hematopoietic stem cells and to develop lentiviral vectors capable of conferring therapeutic levels of gamma-globin gene expression in erythroid cells following hematopoietic stem cell gene transfer. A positive response for either of these approaches could be used as a potential gene-based therapy for individuals with inherited forms of anemia, including sickle cell anemia and beta-thallasemia.
A native of Dawson, Ill., Wilber and his wife, Tiffany, have three children.